Drugs / Hib-MenC-TT vaccine
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00129116 | Mar → Dec 2003 | haemophilus infectious disease, meningococcal infection | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Hib-MenC-TT vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00129116 ↗ |
| Modality | Vaccine | “Hib-MenC-TT vaccine” NCT00129116 ↗ |